Galectin Therapeutics (GALT) Other Working Capital Changes (2010 - 2013)
Galectin Therapeutics' (GALT) quarterly Other Working Capital Changes came in at -$1000.0 in Q4 2013, up 75.0% quarter-over-quarter from -$4000.0 in Q3 2013.
Galectin Therapeutics (GALT) Other Working Capital Changes (2010 - 2013) Analysis & Trends
Galectin Therapeutics' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$1000.0 for Q4 2013.
- On a quarterly basis, Other Working Capital Changes changed N/A year-over-year to -$1000.0 in Q4 2013; TTM through Dec 2013 was -$6000.0, a N/A change from a year earlier, with the FY2013 full-year figure at -$6000.0, down 200.0% from the prior year.
- Other Working Capital Changes climbed to -$1000.0 in Q4 2013 per GALT's latest filing, from -$4000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $801000.0 in Q4 2023 and bottomed at -$467000.0 in Q3 2025.
- The 5-year median for Other Working Capital Changes is -$183000.0 (2023), against an average of -$28529.4.
- Biggest YoY gain for Other Working Capital Changes was 25.0% in 2011; the steepest drop was 25.0% in 2011.
- Year by year, Other Working Capital Changes stood at -$2000.0 in 2010, then sank by 50.0% to -$3000.0 in 2011, then jumped by 66.67% to -$1000.0 in 2013.
- Per Business Quant, the three latest GALT Other Working Capital Changes figures stand at -$1000.0 (Q4 2013), -$4000.0 (Q3 2013), and -$1000.0 (Q1 2013).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Galectin Therapeutics | 227.21 Mn | 227.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -1,000.00 |
| Dec 31, 2013 | -1,000.00 |
| Dec 31, 2013 | -1,000.00 |
| Sep 30, 2013 | -4,000.00 |
| Sep 30, 2013 | -4,000.00 |
| Sep 30, 2013 | -4,000.00 |
| Mar 31, 2013 | -1,000.00 |
| Mar 31, 2013 | -1,000.00 |
| Mar 31, 2013 | -1,000.00 |
| Sep 30, 2011 | -3,000.00 |
| Sep 30, 2011 | -3,000.00 |
| Sep 30, 2011 | -3,000.00 |
| Jun 30, 2011 | -4,000.00 |
| Jun 30, 2011 | -4,000.00 |
| Jun 30, 2011 | -4,000.00 |
| Mar 31, 2011 | -5,000.00 |
| Mar 31, 2011 | -5,000.00 |
| Mar 31, 2011 | -5,000.00 |
| Dec 31, 2010 | -2,000.00 |
| Dec 31, 2010 | -2,000.00 |